Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M546Revenue (TTM) $M35.8Net Margin (%)-238.1Altman Z-Score5.3
Enterprise Value $M415EPS (TTM) $-2.9Operating Margin %-253.7Piotroski F-Score2
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)-253.1Higher ROA y-yN
Price/Book4.210-y EBITDA Growth Rate %--Quick Ratio4.4Cash flow > EarningsY
Price/Sales15.15-y EBITDA Growth Rate %--Current Ratio4.4Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-44.4Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-53.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M29.2ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with NLNK

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

NLNK is held by these investors:



NLNK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Langren Carl W.Principal Accounting Officer 2016-12-14Sell3,943$10.8572.26view
Talarico Ernest IIIDirector 2016-06-06Buy4,065$12.3251.7view
Link Charles J. Jr.Chairman of the Board and CEO 2016-04-07Sell10,000$20.03-6.69view
Link Charles J. Jr.Chairman of the Board and CEO 2016-03-15Sell25,000$17.864.65view
Link Charles J. Jr.Chairman of the Board and CEO 2016-02-03Sell25,000$24.16-22.64view
HENNEMAN JOHN B IIIEVP, CFO 2016-01-05Sell175$35.74-47.71view
Wiley BrianVP of Business Development 2016-01-05Sell1,295$34.99-46.58view
Vahanian Nicholas N.President, Chief Medical Offic 2016-01-05Sell3,011$35.06-46.69view
Vahanian Nicholas N.President, Chief Medical Offic 2015-09-11Sell10,000$51.19-63.49view
Vahanian Nicholas N.President, Chief Medical Offic 2015-08-03Sell10,000$51.77-63.9view

Press Releases about NLNK :

Quarterly/Annual Reports about NLNK:

News about NLNK:

Articles On GuruFocus.com
NewLink Genetics Announces Presentation of Two Abstracts at ASCO Apr 21 2017 
NewLink Genetics to Host Its First Quarter 2017 Financial Results Conference Call on May 4, 2017 Apr 13 2017 
Interim Phase 2 Data Demonstrate Robust Response Rate with Indoximod in Combination with Keytruda Apr 04 2017 
NewLink Genetics Announces Presentation of Two Abstracts at AACR Mar 01 2017 
First Eagle Investment Adds to Stake in NewLink Genetics Feb 03 2016 
These Companies Show High Profit and Low Debt Jun 17 2015 
When A Stock Doubles, Don’t Trim It Automatically May 27 2015 
Greenblatt's Top Buys During First Quarter May 22 2015 
NewLink Genetics Corporation Offers a Risky Way to Generate Income Sep 11 2013 
Weekly CEO Sells Highlight: Universal Insurance Holdings Inc, Avanir Pharmaceuticals Inc, Bel Fuse I Jun 30 2012 

More From Other Websites
Vaunted Ebola Vaccine Faces Questions Apr 24 2017
NewLink Genetics Corp. – Value Analysis (NASDAQ:NLNK) : April 21, 2017 Apr 21 2017
Should Gilead Sciences Acquire NewLink Genetics? Apr 21 2017
NewLink Genetics Announces Presentation of Two Abstracts at ASCO Apr 21 2017
NewLink Genetics Corp. breached its 50 day moving average in a Bullish Manner : NLNK-US : April 20,... Apr 20 2017
Morgan Stanley Ups Incyte Target to $150 Apr 13 2017
The IDO-Inhibitor Race Is On to Improve Cancer Treatment Apr 13 2017
NewLink Genetics to Host Its First Quarter 2017 Financial Results Conference Call on May 4, 2017 Apr 13 2017
ETFs with exposure to NewLink Genetics Corp. : April 7, 2017 Apr 07 2017
NewLink Genetics Corp. breached its 50 day moving average in a Bearish Manner : NLNK-US : April 7,... Apr 07 2017
Why NewLink Genetics, Harmonic, and Innophos Holdings Slumped Today Apr 05 2017
Why NewLink Genetics Shares Fell 10.3% Today Apr 04 2017
NEWLINK GENETICS NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses... Apr 04 2017
NewLink Genetics Corp. stock drops 28% on mid-stage results for melanoma drug Apr 04 2017
Interim Phase 2 Data Demonstrate Robust Response Rate with Indoximod in Combination with Keytruda®... Apr 04 2017
TrovaGene and NewLink Genetics Find Investors Optimistic About Products Mar 31 2017
NewLink Genetics' shares surge after upgrade, seen as takeover target Mar 30 2017
5 Top Performing Stocks of the Best ETF of Q1 Mar 30 2017
Blog Coverage PTC Therapeutics Acquires Rights for Duchenne Muscular Dystrophy Drug from Marathon... Mar 17 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)